- Market Capitalization, $K 164,245
- Shares Outstanding, K 16,278
- Annual Sales, $ 79,040 K
- Annual Income, $ 6,270 K
- 60-Month Beta -0.32
- Price/Sales 2.08
- Price/Cash Flow 25.73
- Price/Book 2.38
|Period||Period Low||Period High||Performance|
| || |
-2.04 (-16.63%)since 11/07/22
| || |
-1.02 (-9.07%)since 09/07/22
| || |
+3.59 (+54.07%)since 12/07/21
ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of -60% and 28.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
Consolidated Water, Ashford Hospitality Trust, BankFinancial, LogicBio Therapeutics and ProPhase Labs are part of the Zacks top Analyst Blog .
A stronger dollar is a boon for Consolidated Water (CWCO), Ashford Hospitality Trust (AHT), BankFinancial (BFIN), LogicBio Therapeutics (LOGC) and ProPhase Labs (PRPH) that have high domestic exposure...
Here is how ProPhase Labs, Inc. (PRPH) and Concert Pharmaceuticals (CNCE) have performed compared to their sector so far this year.
Energy, banks and agriculture have plenty of value stocks this year but what about healthcare?
Does ProPhase Labs, Inc. (PRPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here is how DBV Technologies S.A. (DBVT) and ProPhase Labs, Inc. (PRPH) have performed compared to their sector so far this year.
ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of 233.33% and 28.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Lyra Therapeutics, Inc. (LYRA) delivered earnings and revenue surprises of -26.47% and 92.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...
|Prophase Labs Inc|
|DWA Smallcap Momentum Invesco ETF|
|Total Stock Market ETF Vanguard|
|Avantis U.S. Small Cap Value ETF|
|Extended Market Index ETF Vanguard|
|DJ Select Microcap First Trust|
|3rd Resistance Point||10.59|
|2nd Resistance Point||10.44|
|1st Resistance Point||10.34|
|1st Support Level||10.08|
|2nd Support Level||9.93|
|3rd Support Level||9.82|